Come up with a name for your new list and we'll add to it:
Fate Therapeutics raised a round of funding on May 19, 2009. Investors include
Qualifying Therapeutic Discovery Project.
Fate Therapeutics (NASDAQ: FATE) is a biotechnology company developing stem cell modulators (SCMs), biologic or small molecule compounds that guide cell fate, to treat patients with very few therapeut…